USFDA completes inspection at Granules India’s Virginia facility

11 Dec 2017 Evaluate

Granules India’s wholly-owned foreign subsidiary - Granules Pharmaceuticals, Inc. facility located in Chantilly, Virginia, USA has completed its first audit from December 4, 2017 to December 8, 2017 by the US Food and Drug Administration (USFDA) with one observation. Granules Pharmaceuticals, Inc. will respond to this observation within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).



Granules India Share Price

560.65 -5.90 (-1.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×